Toll Free: 1-888-928-9744

China Oral Antihyperglycemic Drugs Market Research Report to 2020

Published: Jun 22, 2016 | Pages: 127 | Publisher: QYResearch | Industry: Medical Devices | Report Format: Electronic (PDF)

The diabetes market is estimated to reach over $60 billion a year. And Oral Antihyperglycemic Drugs share over 60% of the market. As the the world's most populous country, China has 11.6% diabetes mellitus patients among adults populations, which make China the most potential region of diabetes market.
This report studies Oral Antihyperglycemic Drugs in China market, covering USA, Canada and Mexico, focuses on top players in three Regions, with sales, price, revenue and market share in China market, like
Eli Lilly
AstraZeneca
Bayer
Takeda
Novo Nordisk
Pfizer
Sinofi
Boehringer-Ingelheim
HANSOH PHARMA
HUADONG MEDICINE
LUYE PHARMA
HENGRUI PHARMACEUTICAL
TIPR Pharmaceutical
PKU HEALTHCARE
Jiangsu Heng Rui Medicine


Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into 
Sensitizers
Secretagogues
Alpha-glucosidase inhibitors
DPP-4 inhibitors


 Table of Content
China Oral Antihyperglycemic Drugs Market Research Report to 2020 1 Oral Antihyperglycemic Drugs Overview 1.1 Product Overview and Scope of Oral Antihyperglycemic Drugs 1.2 Oral Antihyperglycemic Drugs Segment by Type 1.2.1 Sensitizers and Sales Growth Rate 2011-2020 1.2.2 Secretagogues and Sales Growth Rate 2011-2020 1.2.3 Alpha-glucosidase inhibitors and Sales Growth Rate 2011-2020 1.2.4 DPP-4 inhibitors and Sales Growth Rate 2011-2020 1.3 Oral Antihyperglycemic Drugs Segment by Population Age 1.3.1 Oral Antihyperglycemic Drugs Sales Market Share by Population Age in 2015 and 2016 1.4 Oral Antihyperglycemic Drugs Market by Regions 1.5 China Market Size (Value and Volume) of Oral Antihyperglycemic Drugs 2011-2020 1.5.1 China Oral Antihyperglycemic Drugs Sales and Growth Rate 2011-2020 1.5.2 China Oral Antihyperglycemic Drugs Revenue and Growth Rate 2011-2020 2 China Oral Antihyperglycemic Drugs Market Competition by Manufacturers 2.1 China Oral Antihyperglycemic Drugs Sales and Share by Manufacturers (2015 and 2016) 2.2 China Oral Antihyperglycemic Drugs Revenue and Share by Manufacturers (2015 and 2016) 2.3 China Oral Antihyperglycemic Drugs Average Price by Manufacturers (2015 and 2016) 2.4 Manufacturers Oral Antihyperglycemic Drugs Manufacturing Base Distribution and Product Type 3 China Oral Antihyperglycemic Drugs Market Analysis by Type and Populations 3.1 China Oral Antihyperglycemic Drugs Sales, Market Share and Growth Rate by Secretagogues 2011-2020 3.2 China Oral Antihyperglycemic Drugs Revenue, Market Share and Growth Rate by Secretagogues 2011-2020 3.3 Oral Antihyperglycemic Drugs Average Price by Type in 2015 3.4 China Oral Antihyperglycemic Drugs Sales, Market Share and Growth Rate by Population 2011-2020 4 China Oral Antihyperglycemic Drugs Manufacturers Analysis 4.1 Eli Lilly 4.1.1 Company Basic Information, Manufacturing Base and Competitors 4.1.2 Oral Antihyperglycemic Drugs Product Segment of Eli Lilly 4.1.2.1 Jardiance and Price in 2015 and 2016 of Eli Lilly 4.1.2.2 Jentadueto and Price in 2015 and 2016 of Eli Lilly 4.1.2.3 Synjardy and Price in 2015 and 2016 of Eli Lilly 4.1.2.4 Tradjenta and Price in 2015 and 2016 of Eli Lilly 4.1.2.5 Trulicity and Price in 2015 and 2016 of Eli Lilly 4.1.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Eli Lilly 2015 to 2016 4.1.4 Interviewee, Name and Contact 4.2 AstraZeneca 4.2.1 Company Basic Information, Manufacturing Base and Competitors 4.2.2 Oral Antihyperglycemic Drugs Product Segment of AstraZeneca 4.2.2.1 Bydureon and Price in 2015 and 2016 of AstraZeneca 4.2.2.2 Byetta and Price in 2015 and 2016 of AstraZeneca 4.2.2.3 Kombiglyze XR and Price in 2015 and 2016 of AstraZeneca 4.2.2.4 Komboglyze and Price in 2015 and 2016 of AstraZeneca 4.2.2.5 Onglyza and Price in 2015 and 2016 of AstraZeneca 4.2.2.6 Symlin and Price in 2015 and 2016 of AstraZeneca 4.2.2.7 XIGDUO XR and Price in 2015 and 2016 of AstraZeneca 4.2.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of AstraZeneca 2015 to 2016 4.2.4 Interviewee, Name and Contact 4.3 Bayer 4.3.1 Company Basic Information, Manufacturing Base and Competitors 4.3.2 Oral Antihyperglycemic Drugs Product Segment of Bayer 4.3.2.1 Glucobay and Price in 2015 and 2016 of Bayer 4.3.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Bayer 2015 to 2016 4.3.4 Interviewee, Name and Contact 4.4 Takeda 4.4.1 Company Basic Information, Manufacturing Base and Competitors 4.4.2 Oral Antihyperglycemic Drugs Product Segment of Takeda by Type 4.4.2.1 ACTOS and Price in 2015 and 2016 of Takeda 4.4.2.2 ACTOPLUS MET and Price in 2015 and 2016 of Takeda 4.4.2.3 ACTOPLUS MET XR and Price in 2015 and 2016 of Takeda 4.4.2.4 DUETACT and Price in 2015 and 2016 of Takeda 4.4.2.5 OSENI and Price in 2015 and 2016 of Takeda 4.4.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Takeda 2015 to 2016 4.4.4 Interviewee, Name and Contact 4.5 Novo Nordisk 4.5.1 Company Basic Information, Manufacturing Base and Competitors 4.5.2 Oral Antihyperglycemic Drugs Product Segment of Novo nordisk by 4.5.2.1 Novonorm and Price in 2015 and 2016 of Novo nordisk 4.5.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Novo nordisk 2015 to 2016 4.5.4 Interviewee, Name and Contact 4.6 Pfizer 4.6.1 Company Basic Information, Manufacturing Base and Competitors 4.6.2 Oral Antihyperglycemic Drugs Product Segment of Pfizer by Type 4.6.2.1 Glucotrol XL and Price in 2015 and 2016 of Pfizer 4.6.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Pfizer 2015 to 2016 4.6.4 Interviewee, Name and Contact 4.7 Sinofi 4.7.1 Company Basic Information, Manufacturing Base and Competitors 4.7.2 Oral Antihyperglycemic Drugs Product Segment of Sinofi 4.7.2.1 Sensitizers and Price in 2015 and 2016 of Sinofi 4.7.2.2 Secretagogues and Price in 2015 and 2016 of Sinofi 4.7.2.3 Alpha-glucosidase inhibitors and Price in 2015 and 2016 of Sinofi 4.7.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Sinofi 2015 to 2016 4.7.4 Interviewee, Name and Contact 4.8 Boehringer-Ingelheim 4.8.1 Company Basic Information, Manufacturing Base and Competitors 4.8.2 Oral Antihyperglycemic Drugs Product Segment of Boehringer-Ingelheim 4.8.2.1 Tradjenta and Price in 2015 and 2016 of Boehringer-Ingelheim 4.8.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Boehringer-Ingelheim 2015 to 2016 4.8.4 Interviewee, Name and Contact 4.9 HANSOH PHARMA 4.9.1 Company Basic Information, Manufacturing Base and Competitors 4.9.2 Oral Antihyperglycemic Drugs Product Segment of HANSOH PHARMA 4.9.2.1 Fulaiyin and Price in 2015 and 2016 of HANSOH PHARMA 4.9.2.2 Fulaihe and Price in 2015 and 2016 of HANSOH PHARMA 4.9.2.3 Fulaidi and Price in 2015 and 2016 of HANSOH PHARMA 4.9.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of HANSOH PHARMA 2015 to 2016 4.9.4 Interviewee, Name and Contact 4.10 HUADONG MEDICINE 4.10.1 Company Basic Information, Manufacturing Base and Competitors 4.10.2 Oral Antihyperglycemic Drugs Product Segment of HUADONG MEDICINE 4.10.2.1 Kaboping and Price in 2015 and 2016 of HUADONG MEDICINE 4.10.2.2 Kashuangping and Price in 2015 and 2016 of HUADONG MEDICINE 4.10.2.3 Kafuping and Price in 2015 and 2016 of HUADONG MEDICINE 4.10.2.4 Kasiping and Price in 2015 and 2016 of HUADONG MEDICINE 4.10.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of HUADONG MEDICINE 2015 to 2016 4.10.4 Interviewee, Name and Contact 4.11 LUYE PHARMA 4.11.1 Company Basic Information, Manufacturing Base and Competitors 4.11.2 Oral Antihyperglycemic Drugs Product Segment of LUYE PHARMA 4.11.2.1 Beikangning and Price in 2015 and 2016 of LUYE PHARMA 4.11.2.2 Beixi and Price in 2015 and 2016 of LUYE PHARMA 4.11.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of LUYE PHARMA 2015 to 2016 4.11.4 Interviewee, Name and Contact 4.12 HENGRUI PHARMACEUTICAL 4.12.1 Company Basic Information, Manufacturing Base and Competitors 4.12.2 Oral Antihyperglycemic Drugs Product Segment of HENGRUI PHARMACEUTICAL 4.12.2.1 Aineng and Price in 2015 and 2016 of HENGRUI PHARMACEUTICAL 4.12.2.2 Xianfudi and Price in 2015 and 2016 of HENGRUI PHARMACEUTICAL 4.12.2.3 Beishun and Price in 2015 and 2016 of HENGRUI PHARMACEUTICAL 4.12.2.4 Shuangneng and Price in 2015 and 2016 of HENGRUI PHARMACEUTICAL 4.12.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of HENGRUI PHARMACEUTICAL 2015 to 2016 4.12.4 Interviewee, Name and Contact 4.13 TIPR Pharmaceutical 4.13.1 Company Basic Information, Manufacturing Base and Competitors 4.13.2 Oral Antihyperglycemic Drugs Product Segment of TIPR Pharmaceutical 4.13.2.1 Jieshi and Price in 2015 and 2016 of TIPR Pharmaceutical 4.13.2.2 Jiebei and Price in 2015 and 2016 of TIPR Pharmaceutical 4.13.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of TIPR Pharmaceutical 2015 to 2016 4.13.4 Interviewee, Name and Contact 4.14 PKU HEALTHCARE 4.14.1 Company Basic Information, Manufacturing Base and Competitors 4.14.2 Oral Antihyperglycemic Drugs Product Segment of TIPR Pharmaceutical 4.14.2.1 Kedeping and Price in 2015 and 2016 of TIPR Pharmaceutical 4.14.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of TIPR Pharmaceutical 2015 to 2016 4.14.4 Interviewee, Name and Contact 4.15 Jiangsu Heng Rui Medicine 4.15.1 Company Basic Information, Manufacturing Base and Competitors 4.15.2 Oral Antihyperglycemic Drugs Product Segment of Jiangsu Heng Rui Medicine 4.15.2.1 Kedeping and Price in 2015 and 2016 of Jiangsu Heng Rui Medicine 4.15.3 Oral Antihyperglycemic Drugs Sales, Revenue, Price of Jiangsu Heng Rui Medicine 2015 to 2016 4.15.4 Interviewee, Name and Contact 5 China Oral Antihyperglycemic Drugs Market Analysis by Regions 5.1.1 China Oral Antihyperglycemic Drugs Sales by Regions 2011-2020 5.1.2 China Oral Antihyperglycemic Drugs Revenue by Regions 2011-2020 5.2 USA Oral Antihyperglycemic Drugs Market 5.2.1 USA Oral Antihyperglycemic Drugs Sales, Revenue and Growth Rate 2011-2020 5.2.2 USA Oral Antihyperglycemic Drugs Sales and Market Share by Manufacturers in 2015 5.2.3 USA Oral Antihyperglycemic Drugs Sales and Market Share by Type in 2015 5.2.4 USA Oral Antihyperglycemic Drugs Sales and Market Share by Applications in 2015 5.3 Canada Oral Antihyperglycemic Drugs Market 5.3.1 Canada Oral Antihyperglycemic Drugs Sales, Revenue and Growth Rate 2011-2020 5.3.2 Canada Oral Antihyperglycemic Drugs Sales and Market Share by Manufacturers in 2015 5.3.3 Canada Oral Antihyperglycemic Drugs Sales and Market Share by Type in 2015 5.3.4 Canada Oral Antihyperglycemic Drugs Sales and Market Share by Applications in 2015 5.4 Mexico Oral Antihyperglycemic Drugs Market 5.4.1 Mexico Oral Antihyperglycemic Drugs Sales, Revenue and Growth Rate 2011-2020 5.4.2 Mexico Oral Antihyperglycemic Drugs Sales and Market Share by Manufacturers in 2015 5.4.3 Mexico Oral Antihyperglycemic Drugs Sales and Market Share by Type in 2015 5.4.4 Mexico Oral Antihyperglycemic Drugs Sales and Market Share by Applications in 2015 6 Oral Antihyperglycemic Drugs Technology and Development Trend 6.1 Oral Antihyperglycemic Drugs Technology Analysis 6.2 Oral Antihyperglycemic Drugs Technology Development Trend Analysis 7 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Oral Antihyperglycemic Drugs Figure Picture of Sensitizers Figure Sensitizers Sales Growth Rate 2011-2020 Figure Picture of Secretagogues Figure Secretagogues Sales Growth Rate 2011-2020 Figure Picture of Alpha-glucosidase inhibitors Figure Alpha-glucosidase inhibitors Sales Growth Rate 2011-2020 Figure Picture of DPP-4 inhibitors Figure DPP-4 inhibitors Sales Growth Rate 2011-2020 Table Oral Antihyperglycemic Drugs Sales Market Share by Applications in 2015 and 2016 Table Oral Antihyperglycemic Drugs Key Clients (Buyers) List in Application 1 Table Oral Antihyperglycemic Drugs Key Clients (Buyers) List in Application 2 Table Oral Antihyperglycemic Drugs Key Clients (Buyers) List in Application 3 Table Oral Antihyperglycemic Drugs Key Clients (Buyers) List in Application 4 Table Oral Antihyperglycemic Drugs Key Clients (Buyers) List in Application 6 Figure USA Oral Antihyperglycemic Drugs Sales and Growth Rate 2011-2020 Figure Canada Oral Antihyperglycemic Drugs Sales and Growth Rate 2011-2020 Figure Mexico Oral Antihyperglycemic Drugs Sales and Growth Rate 2011-2020 Figure China Oral Antihyperglycemic Drugs Sales and Growth Rate 2011-2020 Figure China Oral Antihyperglycemic Drugs Revenue and Growth Rate 2011-2020 Table China Oral Antihyperglycemic Drugs Sales of Key Manufacturers (2015 and 2016) Table China Oral Antihyperglycemic Drugs Sales Share by Manufacturers (2015 and 2016) Table China Oral Antihyperglycemic Drugs Revenue by Manufacturers (2015 and 2016) Table China Oral Antihyperglycemic Drugs Revenue Share by Manufacturers (2015 and 2016) Table China Market Oral Antihyperglycemic Drugs Average Price of Key Manufacturers (2015 and 2016) Table Manufacturers Oral Antihyperglycemic Drugs Manufacturing Base Distribution and Product Type Table China Oral Antihyperglycemic Drugs Sales by Secretagogues011-2020 Table China Oral Antihyperglycemic Drugs Sales Share by Secretagogues011-2020 Table China Oral Antihyperglycemic Drugs Sales Growth Rate by Secretagogues011-2020 Table China Oral Antihyperglycemic Drugs Revenue by Secretagogues011-2020 Table China Oral Antihyperglycemic Drugs Revenue Share by Secretagogues011-2020 Table China Oral Antihyperglycemic Drugs Revenue Growth Rate by Secretagogues011-2020 Table Oral Antihyperglycemic Drugs Average Price by Type in 2015 Table China Oral Antihyperglycemic Drugs Sales by Application 2011-2020 Table China Oral Antihyperglycemic Drugs Sales Market Share by Application 2011-2020 Table China Oral Antihyperglycemic Drugs Sales Growth Rate by Application 2011-2020 Table Company One Basic Information List Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Company One 2015 to 2016 Table Company Two Basic Information List Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Company Two 2015 to 2016 Table Company Three Basic Information List Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Company Three 2015 to 2016 Table Company Four Basic Information List Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Company Four 2015 to 2016 Table Company Five Basic Information List Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Company Five 2015 to 2016 Table Company Six Basic Information List Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Company Six 2015 to 2016 Table Company Seven Basic Information List Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Company Seven 2015 to 2016 Table Company Eight Basic Information List Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Company Eight 2015 to 2016 Table Company Nine Basic Information List Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Company Nine 2015 to 2016 Table Company Ten Basic Information List Table Oral Antihyperglycemic Drugs Sales, Revenue, Price of Company Ten 2015 to 2016 Table China Oral Antihyperglycemic Drugs Sales by Regions 2011-2020 Table China Oral Antihyperglycemic Drugs Sales Market Share by Regions 2011-2020 Figure China Oral Antihyperglycemic Drugs Sales Market Share by Regions 2015 Table China Oral Antihyperglycemic Drugs Revenue by Regions 2011-2020 Table China Oral Antihyperglycemic Drugs Revenue Market Share by Regions 2011-2020 Figure China Oral Antihyperglycemic Drugs Revenue Market Share by Regions 2015 Figure USA Oral Antihyperglycemic Drugs Sales and Growth Rate 2011-2020 Figure USA Oral Antihyperglycemic Drugs Revenue and Growth Rate 2011-2020 Table USA Oral Antihyperglycemic Drugs Sales and Market Share by Manufacturers in 2015 Table USA Oral Antihyperglycemic Drugs Sales and Market Share by Type in 2015 Table USA Oral Antihyperglycemic Drugs Sales and Market Share by Applications in 2015 Figure Canada Oral Antihyperglycemic Drugs Sales and Growth Rate 2011-2020 Figure Canada Oral Antihyperglycemic Drugs Revenue and Growth Rate 2011-2020 Table Canada Oral Antihyperglycemic Drugs Sales and Market Share by Manufacturers in 2015 Table Canada Oral Antihyperglycemic Drugs Sales and Market Share by Type in 2015 Table Canada Oral Antihyperglycemic Drugs Sales and Market Share by Applications in 2015 Figure Mexico Oral Antihyperglycemic Drugs Sales and Growth Rate 2011-2020 Figure Mexico Oral Antihyperglycemic Drugs Revenue and Growth Rate 2011-2020 Table Mexico Oral Antihyperglycemic Drugs Sales and Market Share by Manufacturers in 2015 Table Mexico Oral Antihyperglycemic Drugs Sales and Market Share by Type in 2015 Table Mexico Oral Antihyperglycemic Drugs Sales and Market Share by Applications in 2015



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global microcontroller market is estimated to be valued at USD 26.9 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing demand in key application areas such as automotive, consumer electronics and healthcare is expected to

Read More...

Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the marke

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...

Global engineering service outsourcing market size is likely to be valued at USD 415.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Rapid alignment of OEMs accompanied by increasing focus on efficient performance and reliab

Read More...

Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to driv

Read More...
Choose License Type
Single User - US $2750
Multi User - US $5500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify